header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
100% of the animals spontaneously tumor in the distal part of the colon after 7 month of age, or within 5 weeks after bone marrow transfer. The […]
LGI1 (leucine-rich, glioma-inactivated 1) mutations are responsible for an inherited focal epileptic syndrome with onset in adolescence. LGI1-related […]
Flt-3/Flk-2 Antibody (SF1.340) is a mouse monoclonal IgG1 (kappa light chain) […]
This antibody recognizes the human KIAA0753 protein (also named OFIP or MNR). The epitope is located at the carboxy terminus of the protein, between […]
Mouse monoclonal antibodies recognizing the HOX11 gene product. […]
Mouse monoclonal antibodies recognizing the Hox11L2 gene product. […]
This proposition describes a technique that allowed us to successfully stain human tissues with fluorochrome labelled antibodies for confocal and […]
We have recently contributed to establish a robust xenotransplantation model (NSG, NRG) to study the leukemic engraftment as well as the stem cell […]
This antibody recognizes the human KIAA0753 protein (also named OFIP or MNR). The epitope is located […]
This proposition describes a technique that allowed us to successfully stain human tissues with […]
LGI1 (leucine-rich, glioma-inactivated 1) mutations are responsible for an inherited focal epileptic […]
100% of the animals spontaneously tumor in the distal part of the colon after 7 month of age, or […]
We have recently contributed to establish a robust xenotransplantation model (NSG, NRG) to study the […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.